Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PHARMACIE RANDRIANARIVONY ET ASSOCIES : revenue, balance sheet and financial ratios

PHARMACIE RANDRIANARIVONY ET ASSOCIES is a French company founded 9 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in EVRON (53150), this company of category PME shows in 2024 a net income positive of 80 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE RANDRIANARIVONY ET ASSOCIES (SIREN 823174438)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C N/C N/C N/C
Net income 79 974 € 58 720 € 100 231 € 107 121 € 119 113 € 97 928 € 111 550 € 53 322 €
EBITDA N/C N/C N/C N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, PHARMACIE RANDRIANARIVONY ET ASSOCIES generates positive net income of 80 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 53 k€ -> 80 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

79 974 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 70%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 51%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

70.329%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

50.667%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

40.8%

Solvency indicators evolution
PHARMACIE RANDRIANARIVONY ET ASSOCIES

Sector positioning

Debt ratio
70.33 2024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average -7 pts over 3 years

In 2024, the debt ratio of PHARMACIE RANDRIANARIVONY... (70.33) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
50.67% 2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good +9 pts over 3 years

In 2024, the financial autonomy of PHARMACIE RANDRIANARIVONY... (50.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 181.02. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

181.019

Liquidity indicators evolution
PHARMACIE RANDRIANARIVONY ET ASSOCIES

Sector positioning

Liquidity ratio
181.02 2024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average -13 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE RANDRIANARIVONY... (181.02) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Positioning of PHARMACIE RANDRIANARIVONY ET ASSOCIES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of PHARMACIE RANDRIANARIVONY ET ASSOCIES is estimated at 1 116 496 € (range 777 510€ - 1 670 342€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
777k€ 1116k€ 1670k€
1 116 496 € Range: 777 510€ - 1 670 342€
NAF 5 année 2024

Valuation method used

Net Income Multiple
79 974 € × 14.0x = 1 116 496 €
Range: 777 510€ - 1 670 342€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE RANDRIANARIVONY ET ASSOCIES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE RANDRIANARIVONY ET ASSOCIES

What is the revenue of PHARMACIE RANDRIANARIVONY ET ASSOCIES ?

The revenue of PHARMACIE RANDRIANARIVONY ET ASSOCIES is not publicly disclosed (confidential accounts filed with INPI).

Is PHARMACIE RANDRIANARIVONY ET ASSOCIES profitable?

Yes, PHARMACIE RANDRIANARIVONY ET ASSOCIES generated a net profit of 80 k€ in 2024.

Where is the headquarters of PHARMACIE RANDRIANARIVONY ET ASSOCIES ?

The headquarters of PHARMACIE RANDRIANARIVONY ET ASSOCIES is located in EVRON (53150), in the department Mayenne.

Where to find the tax return of PHARMACIE RANDRIANARIVONY ET ASSOCIES ?

The tax return of PHARMACIE RANDRIANARIVONY ET ASSOCIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE RANDRIANARIVONY ET ASSOCIES operate?

PHARMACIE RANDRIANARIVONY ET ASSOCIES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.